NO20006268D0 - <Beta>karbolinforbindelser - Google Patents
<Beta>karbolinforbindelserInfo
- Publication number
- NO20006268D0 NO20006268D0 NO20006268A NO20006268A NO20006268D0 NO 20006268 D0 NO20006268 D0 NO 20006268D0 NO 20006268 A NO20006268 A NO 20006268A NO 20006268 A NO20006268 A NO 20006268A NO 20006268 D0 NO20006268 D0 NO 20006268D0
- Authority
- NO
- Norway
- Prior art keywords
- karbolinforbindelser
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9729798A | 1998-06-12 | 1998-06-12 | |
| US8918098P | 1998-06-12 | 1998-06-12 | |
| PCT/US1999/012874 WO1999064420A1 (en) | 1998-06-12 | 1999-06-08 | β-CARBOLINE COMPOUNDS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20006268D0 true NO20006268D0 (no) | 2000-12-11 |
| NO20006268L NO20006268L (no) | 2001-01-29 |
| NO319532B1 NO319532B1 (no) | 2005-08-29 |
Family
ID=26780327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006268A NO319532B1 (no) | 1998-06-12 | 2000-12-11 | <Beta>karbolinforbindelser,anvendelser av dem og farmasoytiske forbindelser som inneholder dem. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6586445B1 (no) |
| EP (1) | EP1086101B1 (no) |
| JP (1) | JP2002517500A (no) |
| KR (1) | KR20010071461A (no) |
| CN (1) | CN1169808C (no) |
| AR (1) | AR019153A1 (no) |
| AT (1) | ATE229954T1 (no) |
| AU (1) | AU761020B2 (no) |
| CA (1) | CA2335339A1 (no) |
| CZ (1) | CZ20004580A3 (no) |
| DE (1) | DE69904595T2 (no) |
| DK (1) | DK1086101T3 (no) |
| ES (1) | ES2188184T3 (no) |
| HU (1) | HUP0302962A2 (no) |
| IL (1) | IL140197A0 (no) |
| NO (1) | NO319532B1 (no) |
| NZ (1) | NZ508765A (no) |
| PL (1) | PL345589A1 (no) |
| RU (1) | RU2233841C2 (no) |
| TW (1) | TWI236477B (no) |
| WO (1) | WO1999064420A1 (no) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2796945B1 (fr) * | 1999-07-30 | 2002-06-28 | Sod Conseils Rech Applic | Nouveaux derives d'hydantoines, de thiohydantoines, de pyrimidinediones et de thioxopyrimidinones, leurs procedes de preparation et leur application a titre de medicaments |
| US6696418B1 (en) | 1999-09-01 | 2004-02-24 | Pfizer Inc. | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| FR2812546B1 (fr) * | 2000-08-01 | 2008-11-21 | Sod Conseils Rech Applic | Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments |
| TWI283577B (en) * | 1999-10-11 | 2007-07-11 | Sod Conseils Rech Applic | Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof |
| US6495589B2 (en) | 2000-04-28 | 2002-12-17 | Pfizer Inc. | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| US6720330B2 (en) | 2000-11-17 | 2004-04-13 | Pfizer Inc. | Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| FR2818978B1 (fr) * | 2000-12-28 | 2003-02-28 | Sod Conseils Rech Applic | Modulateurs de canaux sodiques derives de 2-piperidylimidazoles |
| GB0108337D0 (en) | 2001-04-03 | 2001-05-23 | Novartis Ag | Organic compounds |
| TWI248438B (en) * | 2001-04-10 | 2006-02-01 | Sod Conseils Rech Applic | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| CA2450446A1 (en) * | 2001-06-25 | 2003-01-03 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R | Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof |
| DE10136842A1 (de) * | 2001-07-23 | 2003-02-13 | Schering Ag | GABA¶A¶-Rezeptor-Modulatoren mit NMDA-antagonistischer Aktivität |
| TWI329111B (en) | 2002-05-24 | 2010-08-21 | X Ceptor Therapeutics Inc | Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| US7595311B2 (en) | 2002-05-24 | 2009-09-29 | Exelixis, Inc. | Azepinoindole derivatives as pharmaceutical agents |
| PA8586801A1 (es) | 2002-10-31 | 2005-02-04 | Pfizer | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso |
| DE10252667A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| EP1590349A1 (en) | 2003-01-27 | 2005-11-02 | Pfizer Inc. | Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| NZ568459A (en) | 2003-05-05 | 2009-06-26 | Probiodrug Ag | Use of effectors of glutaminyl and glutamate cyclases |
| ZA200508439B (en) | 2003-05-05 | 2007-03-28 | Probiodrug Ag | Medical use of inhibitors of glutaminyl and glutamate cyclases |
| US7872133B2 (en) | 2003-06-23 | 2011-01-18 | Ono Pharmaceutical Co., Ltd. | Tricyclic heterocycle compound |
| NZ546322A (en) | 2003-10-15 | 2008-11-28 | Probiodrug Ag | Use of effectors of glutaminyl and glutamate cyclases |
| DE10360792A1 (de) * | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE10360793A1 (de) * | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DK1713780T3 (da) * | 2004-02-05 | 2012-05-07 | Probiodrug Ag | Hidtil ukendte inhibitorer af glutaminylcyklase |
| CA2554809C (en) * | 2004-02-05 | 2014-04-29 | Probiodrug Ag | Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase |
| DE602005002746T2 (de) | 2004-04-26 | 2008-02-07 | Pfizer Inc. | Inhibitoren des hiv-integrase-enzyms |
| MXPA06012449A (es) | 2004-04-26 | 2007-01-17 | Pfizer | Inhibidores de la enzima integrasa de vih. |
| DE102004039382A1 (de) * | 2004-08-13 | 2006-02-23 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| EP1829874B1 (en) | 2004-12-22 | 2014-02-12 | Ono Pharmaceutical Co., Ltd. | Tricyclic compound and use thereof |
| PA8663501A1 (es) | 2005-02-17 | 2006-11-09 | Wyeth Wyeth | Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilcondensados |
| MY158766A (en) * | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| JP5035865B2 (ja) * | 2005-09-26 | 2012-09-26 | 国立大学法人高知大学 | Helicobacterpylori菌株の増殖・運動抑制方法 |
| US20070149557A1 (en) * | 2005-11-21 | 2007-06-28 | Amgen Inc. | CXCR3 antagonists |
| US7879859B2 (en) * | 2005-11-21 | 2011-02-01 | Merck Sharp & Dohme Corp. | Diagnosis and treatment of type 2 diabetes and other disorders |
| BRPI0618863A2 (pt) * | 2005-11-23 | 2016-09-13 | Painceptor Pharma Corp | métodos de modular a atividade de um canal iônico dependente e de tratar dor, uma transtorno associado aos sistemas genitourinário ou gastrointestinal em um indivíduo e, composto |
| WO2007115409A1 (en) * | 2006-04-10 | 2007-10-18 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
| DE102006046745A1 (de) * | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| AU2008276568A1 (en) * | 2007-07-19 | 2009-01-22 | Merck & Co., Inc. | Beta carboline derivatives as antidiabetic compounds |
| CN105218565A (zh) * | 2008-10-17 | 2016-01-06 | 泽农医药公司 | 螺羟吲哚化合物及其作为治疗剂的用途 |
| AU2009309008A1 (en) * | 2008-10-29 | 2010-05-06 | Merck Sharp & Dohme Corp. | Triazole beta carboline derivatives as antidiabetic compounds |
| TW201028414A (en) * | 2009-01-16 | 2010-08-01 | Merck Sharp & Dohme | Oxadiazole beta carboline derivatives as antidiabetic compounds |
| CN102844029A (zh) * | 2009-12-28 | 2012-12-26 | 奥迪欧医药设备有限公司 | 用于治疗听力损伤和眩晕的β-咔啉 |
| WO2011088025A1 (en) | 2010-01-15 | 2011-07-21 | Merck Sharp & Dohme Corp. | Oxadiazole beta carboline derivatives as antidiabetic compounds |
| KR101256588B1 (ko) * | 2010-02-17 | 2013-04-19 | 부산대학교 산학협력단 | 베타-카르볼린 알칼로이드를 함유하는 멜라닌 생성 촉진용 조성물 |
| DK2691394T3 (en) * | 2011-03-28 | 2017-08-28 | Sjt Molecular Res S L | RELATIONSHIPS FOR TREATMENT OF METABOLIC SYNDROME |
| CN105837569B (zh) * | 2016-04-29 | 2017-12-26 | 华南农业大学 | 一种骆驼蓬碱噁唑啉类化合物及其制备方法和应用 |
| CN107118212B (zh) * | 2017-05-26 | 2019-12-03 | 广西师范大学 | 1-吡啶-6-甲氧基-9-(3-碘苄)-β-咔啉、合成和应用 |
| CN107163041B (zh) * | 2017-05-26 | 2019-06-21 | 广西师范大学 | 一种β-咔啉化合物及其合成方法和应用 |
| CN106995440B (zh) * | 2017-05-26 | 2019-09-03 | 广西师范大学 | 1-吡啶-6-甲氧基-9-(2,3,4,5-四氟苄基)β-咔啉化合物及其合成方法和应用 |
| CN107141285B (zh) * | 2017-05-26 | 2019-12-03 | 广西师范大学 | 1-吡啶-6-甲氧基-9-甲基苄-β-咔啉及其合成和应用 |
| AR121683A1 (es) * | 2020-03-31 | 2022-06-29 | Takeda Pharmaceuticals Co | Derivados de n-heteroarilalquil-2-(heterociclil y heterociclilmetil)acetamida como agonistas de sstr4 |
| CN115466316A (zh) * | 2021-06-10 | 2022-12-13 | 首都医科大学 | 抑制迁移的1-咪唑-β-咔啉-3-甲酰-RGDF及制备,抗癌转移作用和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378803A (en) * | 1987-12-11 | 1995-01-03 | Sterling Winthrop Inc. | Azole-fused peptides and processes for preparation thereof |
| DE4118741A1 (de) * | 1991-06-05 | 1992-12-10 | Schering Ag | Neue hetaryloxy-(beta)-carboline, deren herstellung und verwendung in arzneimitteln |
| RU2067980C1 (ru) * | 1992-06-30 | 1996-10-20 | Глэксо Груп Лимитед | Производные лактама и фармацевтическая композиция, являющаяся антагонистом 5-окситраптамина /5-нт/ на 5- нт3 -рецепторах или их физиологически приемлемые соли и соловаты |
| RU2068847C1 (ru) * | 1994-05-18 | 1996-11-10 | Всероссийский научный центр по безопасности биологически активных веществ | ПРОИЗВОДНЫЕ 3,4-ДИГИДРО- ИЛИ 1,2,3,4-ТЕТРАГИДРО- β -КАРБОЛИНОВ ИЛИ ИХ СОЛИ С ОРГАНИЧЕСКИМИ ИЛИ НЕОРГАНИЧЕСКИМИ КИСЛОТАМИ, ПРОЯВЛЯЮЩИЕ АНТИМИКРОБНУЮ АКТИВНОСТЬ |
-
1999
- 1999-06-08 AT AT99928479T patent/ATE229954T1/de not_active IP Right Cessation
- 1999-06-08 AU AU45536/99A patent/AU761020B2/en not_active Ceased
- 1999-06-08 DK DK99928479T patent/DK1086101T3/da active
- 1999-06-08 ES ES99928479T patent/ES2188184T3/es not_active Expired - Lifetime
- 1999-06-08 HU HU0302962A patent/HUP0302962A2/hu unknown
- 1999-06-08 CZ CZ20004580A patent/CZ20004580A3/cs unknown
- 1999-06-08 WO PCT/US1999/012874 patent/WO1999064420A1/en not_active Ceased
- 1999-06-08 KR KR1020007014116A patent/KR20010071461A/ko not_active Ceased
- 1999-06-08 JP JP2000553429A patent/JP2002517500A/ja active Pending
- 1999-06-08 US US09/719,455 patent/US6586445B1/en not_active Expired - Lifetime
- 1999-06-08 RU RU2001101433/04A patent/RU2233841C2/ru not_active IP Right Cessation
- 1999-06-08 CA CA002335339A patent/CA2335339A1/en not_active Abandoned
- 1999-06-08 PL PL99345589A patent/PL345589A1/xx not_active Application Discontinuation
- 1999-06-08 DE DE69904595T patent/DE69904595T2/de not_active Expired - Fee Related
- 1999-06-08 EP EP99928479A patent/EP1086101B1/en not_active Expired - Lifetime
- 1999-06-08 CN CNB998081612A patent/CN1169808C/zh not_active Expired - Fee Related
- 1999-06-08 NZ NZ508765A patent/NZ508765A/en unknown
- 1999-06-08 IL IL14019799A patent/IL140197A0/xx unknown
- 1999-06-11 AR ARP990102812A patent/AR019153A1/es not_active Application Discontinuation
- 1999-08-11 TW TW088109827A patent/TWI236477B/zh not_active IP Right Cessation
-
2000
- 2000-12-11 NO NO20006268A patent/NO319532B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0302962A2 (hu) | 2003-12-29 |
| NZ508765A (en) | 2003-10-31 |
| WO1999064420A1 (en) | 1999-12-16 |
| NO20006268L (no) | 2001-01-29 |
| CN1169808C (zh) | 2004-10-06 |
| NO319532B1 (no) | 2005-08-29 |
| EP1086101B1 (en) | 2002-12-18 |
| RU2233841C2 (ru) | 2004-08-10 |
| ES2188184T3 (es) | 2003-06-16 |
| DE69904595T2 (de) | 2003-11-27 |
| KR20010071461A (ko) | 2001-07-28 |
| IL140197A0 (en) | 2002-02-10 |
| TWI236477B (en) | 2005-07-21 |
| PL345589A1 (en) | 2001-12-17 |
| DE69904595D1 (de) | 2003-01-30 |
| AU761020B2 (en) | 2003-05-29 |
| DK1086101T3 (da) | 2003-03-31 |
| AR019153A1 (es) | 2001-12-26 |
| EP1086101A1 (en) | 2001-03-28 |
| CZ20004580A3 (cs) | 2001-12-12 |
| JP2002517500A (ja) | 2002-06-18 |
| HK1032049A1 (en) | 2001-07-06 |
| ATE229954T1 (de) | 2003-01-15 |
| AU4553699A (en) | 1999-12-30 |
| CN1308632A (zh) | 2001-08-15 |
| CA2335339A1 (en) | 1999-12-16 |
| US6586445B1 (en) | 2003-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20006268D0 (no) | <Beta>karbolinforbindelser | |
| NO20005337L (no) | Polyol-IFN-<BETA>-konjugater | |
| ID26301A (id) | Tabung pitot-statis | |
| NO20015015L (no) | Östrogenreseptor-<beta>-ligander | |
| DK1070058T3 (da) | (4-Arylsulfonylamino)-tetrahydropyran-4-carboxylsyrehydroxamider | |
| ATE341990T1 (de) | Sigmidoskop | |
| DE59911453D1 (de) | Aktivkohlefilter | |
| NO20010382L (no) | Agglutineringsundersökelse | |
| EP1062326A4 (en) | GLYKOSYLSULFOTRANSFERASE-3 | |
| DE59907306D1 (de) | Fadenchangierung | |
| ID23287A (id) | Trisiklik tersubstitusi | |
| DE69922063D1 (de) | Fesselballon | |
| DE59906931D1 (de) | Exzenterzahnradgetriebe | |
| DE59911683D1 (de) | Fahrzeugschliessanlage | |
| NO20014010D0 (no) | <beta>-alaninderivater | |
| NO20013013L (no) | <alfa>v<beta>6-integrininhibitorer | |
| DE59903966D1 (de) | Exzenterzahnradgetriebe | |
| ID23219A (id) | Trisiklik tersubstitusi | |
| DE59908769D1 (de) | N-arylsulfonyl-aminosäure-omega-amide | |
| DE59903106D1 (de) | Tripode-gleichlaufdrehgelenk | |
| DE59908057D1 (de) | Underdruckhandhabungseinrichung | |
| NO991030L (no) | Sykloidpropell | |
| DE59807217D1 (de) | Nadellager | |
| DE59808995D1 (de) | Endomikroskopsystem | |
| DE19842103B4 (de) | Stanznietzuführung |